Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion
dc.contributor.author | Tamai, Yoshiko | |
dc.contributor.author | Ohto, Hitoshi | |
dc.contributor.author | Yasuda, Hiroyasu | |
dc.contributor.author | Takeshita, Akihiro | |
dc.contributor.author | Fujii, Nobuharu | |
dc.contributor.author | Ogo, Hiroaki | |
dc.contributor.author | Yazawa, Yurika | |
dc.contributor.author | Hato, Takaaki | |
dc.contributor.author | Mitani, Kinuko | |
dc.contributor.author | Suzuki, Keijiro | |
dc.contributor.author | Yokohama, Akihiko | |
dc.contributor.author | Kato, Yoko | |
dc.contributor.author | Abe, Misao | |
dc.contributor.author | Kumagawa, Midori | |
dc.contributor.author | Ueda, Yasunori | |
dc.contributor.author | Nollet, Kenneth E. | |
dc.contributor.author | Cooling, Laura | |
dc.contributor.author | Kitazawa, Junichi | |
dc.date.accessioned | 2021-10-05T15:06:46Z | |
dc.date.available | 2022-10-05 11:06:44 | en |
dc.date.available | 2021-10-05T15:06:46Z | |
dc.date.issued | 2021-09 | |
dc.identifier.citation | Tamai, Yoshiko; Ohto, Hitoshi; Yasuda, Hiroyasu; Takeshita, Akihiro; Fujii, Nobuharu; Ogo, Hiroaki; Yazawa, Yurika; Hato, Takaaki; Mitani, Kinuko; Suzuki, Keijiro; Yokohama, Akihiko; Kato, Yoko; Abe, Misao; Kumagawa, Midori; Ueda, Yasunori; Nollet, Kenneth E.; Cooling, Laura; Kitazawa, Junichi (2021). "Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion." Transfusion 61(9): 2718-2726. | |
dc.identifier.issn | 0041-1132 | |
dc.identifier.issn | 1537-2995 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/170235 | |
dc.description.abstract | BackgroundAnti‐M is frequently observed as a naturally occurring antibody of little clinical significance. Naturally occurring anti‐M is often found in children although the specific triggers of production, persistence, and evanescence of anti‐M have yet to be elucidated.MethodsIn a retrospective, multicenter, nationwide cohort survey conducted from 2001 to 2015, alloantibody screening was performed before and after transfusion in 18,944 recipients younger than 20 years. Recipients were categorized into six cohorts based on their age at transfusion; within and among these cohorts, allo‐anti‐M was analyzed in regard to its production, persistence, and evanescence.ResultsIn 44 patients, anti‐M detected before and/or after transfusion was an age‐related phenomenon, with a median age of 2 years and an interquartile range of 1–3 years; anti‐M was most frequently detected in a cohort of children 1 to <5 years (0.77%, 31 of 4035). At least five patients were presumed to have concurrent infections. Among 1575 adolescents/young adults (15 to <20 years), no anti‐M was detected. Of 29 patients with anti‐M prior to transfusion, the antibody fell to undetectable levels in 17 recipients (89.5%, of whom at least 13 received only M‐negative red cells) after anywhere from 5 days to 5.8 years; anti‐M persisted in 2, and was not tested in 10. Only 15 recipients (0.08%) produced new anti‐M after transfusion.ConclusionNaturally occurring anti‐M is a phenomenon of younger ages, predominantly between 1 and 3 years. After transfusion, it often falls to undetectable levels. | |
dc.publisher | John Wiley & Sons, Inc. | |
dc.subject.other | anti‐M | |
dc.subject.other | child | |
dc.subject.other | infection | |
dc.subject.other | naturally occurring antibody | |
dc.title | Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Oncology and Hematology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/170235/1/trf16594.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/170235/2/trf16594_am.pdf | |
dc.identifier.doi | 10.1111/trf.16594 | |
dc.identifier.source | Transfusion | |
dc.identifier.citedreference | Tamai Y, Ohto H, Takahashi H, Kitazawa J, for the Pediatric RBC Alloimmunization Consortium. Transfusion‐related alloimmunization to red blood cell antigens in Japanese pediatric recipients. Transfus Med Rev. 2021; 35: 29 – 36. | |
dc.identifier.citedreference | Strahl M, Pettenkofer HJ, Hasse W. A haemolytic transfusion reaction due to anti‐M. Vox Sang. 1955; 5: 34. | |
dc.identifier.citedreference | Kao YS, Frank S, De Jongh DS. Anti‐M in children with acute bacterial infections. Transfusion. 1978; 18: 320 – 2. | |
dc.identifier.citedreference | Mandrell RE, Apicella MA. Lipo‐oligosaccharide (LOS) of mucosal pathogens: molecular mimicry and host‐modification of LOS. Immunology. 1993; 187: 382 – 402. | |
dc.identifier.citedreference | Baine I, Bahar B, Hendrickson JE, Hudson KE, Tormey CA. Microbial pathogen primary sequence inversely correlates with blood group antigen immunogenicity. Transfusion. 2019; 59: 1651 – 6. | |
dc.identifier.citedreference | Burkart PT, Hsu TCS. IgM cold‐warm hemolysis in infectious mononucleosis. Transfusion. 1979; 19: 535 – 8. | |
dc.identifier.citedreference | Cooling L. Kids, colds, and complement: paroxysmal cold hemoglobinuria. Transfusion. 2017; 57: 1332 – 5. | |
dc.identifier.citedreference | Varki A, Gagneux P. Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci. 2012; 1253: 16 – 36. | |
dc.identifier.citedreference | Issitt OD, Anstee D. Applied blood group serology. 4th ed. Durham, NC: Montgomery Scientific Publications; 1998. | |
dc.identifier.citedreference | Melland C, Nance S. Other blood group systems and antigens. In: Cohn CS, Delay M, Johnson ST, Katz LM, editors. Technical manual. 20th ed. Bethesda, MD: AABB; 2020. p. 355 – 88. | |
dc.identifier.citedreference | Schonewille H, Brand A. Alloimmunization to red cell antigens after universal leucodepletion. A regional multicentre retrospective study. Br J Haematol. 2005; 129: 151 – 6. | |
dc.identifier.citedreference | Takeshita A, Watanabe H, Yamada C, Nadarajan VS, Permpikul P, Sinkitjasub A, et al. Erythrocyte alloimmunity and genetic variance: results from the collaborative study of aloimmunity to antigen diversity in Asian populations (all ADP). Transfus Apher Sci. 2020; 59: 102944. | |
dc.identifier.citedreference | Klein HG, Anstee DJ. Other red cell antigens. In: Klein HG, Anstee DJ, editors. Mollison’s blood transfusion in clinical medicine. 11th ed. London: Blackwell Science; 2005. p. 209 – 52. | |
dc.identifier.citedreference | Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev. 2015; 28: 801 – 70. | |
dc.identifier.citedreference | Ohto H, Denomme GA, Ito S, Ishida A, Nollet KE, Yasuda H. Three non‐classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti‐Kell, anti‐Ge3, anti‐M, and anti‐Jr a cases. Transfus Apher Sci. 2020; 59: 102949. | |
dc.identifier.citedreference | Arndt PA, Garratty G, Daniels G, Green CA, Wilkes AM, Hunt P, et al. Late onset neonatal anaemia due to maternal anti‐Ge: possible association with destruction of erythroid progenitors. Transfus Med. 2005; 15: 125 – 32. | |
dc.identifier.citedreference | Andersen LH, Jacob EK, McThenia SS, Tausher CD, Patterson ER, Oliveira JL, et al. Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti‐M reacting optimally at cold temperature. Transfusion. 2021; 61: 974 – 8. | |
dc.identifier.citedreference | Ishida A, Ohto H, Yasuda H, Negishi Y, Tsuiki H, Arakawa T, et al. Anti‐M antibody induced prolonged anemia following hemolytic disease of the newborn due to erythropoietic suppression in 2 siblings. J Pediatr Hematol Oncol. 2015; 37: 375 – 7. | |
dc.identifier.citedreference | Li S, He Z, Luo Y, Ji Y, Luo G, Fang Q, et al. Distribution of maternal red cell antibodies and the risk of severe alloimmune haemolytic disease of the foetus in a Chinese population: a cohort study on prenatal management. BMC Pregnancy Childbirth. 2020; 20: 539. | |
dc.identifier.citedreference | Yasuda H, Ohto H, Nollet KE, Kawabata K, Saito S, Yagi Y, et al. Hemolytic disease of the fetus and newborn with late‐onset anemia due to anti‐M: a case report and review of the Japanese literature. Transfus Med Rev. 2014; 28: 1 – 6. | |
dc.identifier.citedreference | Shah SP, Kalgutkar SM, Sawant RB, Deshpande AS. Anti‐M antibodies: biphasic (reactive at room temperature and at 37 °C): a case series. Asian J Transfus Sci. 2016; 10: 159 – 60. | |
dc.identifier.citedreference | Sancho JM, Pujol M, Fernandez F, Soler M, Manzano P, Fellu E. Delayed haemolytic transfusion reaction due to anti‐M antibody. Br J Haematol. 1998; 103: 268 – 9. | |
dc.identifier.citedreference | Furlong MB Jr, Monaghan WP. Delayed haemolytic episodes due to anti‐M. Transfusion. 1981; 21: 45 – 9. | |
dc.identifier.citedreference | Alperin JB, Riglin H, Branch DR, Gallagher MT, Petz LD. Anti‐M causing delayed hemolytic transfusion reaction. Transfusion. 1983; 23: 322 – 4. | |
dc.identifier.citedreference | Yamada C, Takeshita A, Ohto H, Ishimaru K, Kawabata K, Nomaguchi Y, et al. A Japanese multi‐institutional collaborative study of antigen‐positive red blood cell (RBC) transfusions in patients with corresponding RBC antibodies. Vox Sang. 2020; 115: 456 – 65. | |
dc.identifier.citedreference | Tomoda Y, Higashihara T, Endo T, Ono S, Kanemitsu Y, Kishino K, et al. A prospective clinical trial of hemolytic reaction in patients with positive cold‐reactive antibodies following transfusion of corresponding antigen. Jpn J Transfus Cell Ther. 2013; 59: 733 – 9. | |
dc.identifier.citedreference | Tormey CA, Stack G. The persistence and evanescence of blood group alloantibodies in men. Transfusion. 2009; 49: 505 – 12. | |
dc.identifier.citedreference | Ngoma AM, Mutombo PB, Ikeda K, Nollet KE, Natukunda B, Ohto H. A systematic review of red blood cell alloimmunization in pregnant women in Africa: time to do better. ISBT Sci Series. 2016; 11: 62 – 9. | |
dc.identifier.citedreference | De Young‐Owens A, Kennedy M, Rose RL, Boyle J, O’Shaughnessy R. Anti‐M isoimmunization: management and outcome at the Ohio State University from 1969 to 1995. Obstet Gynecol. 1997; 90: 962 – 6. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.